Fig. 4From: A LASSO-derived model for the prediction of nonattainment of target LDL-C reduction with PCSK9 inhibitors in patients with atherosclerotic cardiovascular diseaseReceiver operating characteristic (ROC) curves for the derivation set (A) and the validation set (B)Back to article page